Endocrine Abstracts

Aim: To single out polineuropathy development risk group.Materials and methods: Four hundred and fifty patients with a more than 5 years diabetes experience were examined.For verification of a diabetic polyneuropathy the electroneuromyography was made. By a method of the immunofermental analysis neurospecific S100 protein level was defined. Data are presented in Me (Q25; Q75) format. The importance of distinctions was estimated by ...